Thu, Apr 24, 2014, 1:08 PM EDT - U.S. Markets close in 2 hrs 52 mins

Recent

% | $
Quotes you view appear here for quick access.

Neurocrine Biosciences Inc. Message Board

  • beachbarbob beachbarbob Jun 29, 2006 12:00 AM Flag

    pinhead doesn't have a clue on why Pfiz

    Pfizer pulled the plug, pump pump pump thats all pinhead knows, no fact just a bunch of crapola.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • you don't know why either - you also don't seem to understand that (1) efficacy ultimately sells drugs - not sheer #'s of sales reps (2) you also don't seem to be able to understand that a more potent drug that is has much higher affinity and is much more selective can be more efficacy and safer

      you also seem to think that lunesta will be able to be sold once somebody in the media gets a hold of that FDA form info with the neoplasia rates of 5+ % and the mutagenicity in animals

      • 2 Replies to pinvestment
      • If you did your home work Lunesta has as good a label as it gets and at this point a real label, Indiplon has no approved label for comparison, your comments are just more fluff, The battle will be about marketing, plain and simple and it will be a crowded space by FY09.

      • oh! the big stock investment guy can't tell the world why pfizer pulled the plug before Indiplon FDA meeting after spending $500M on this program. Please also tell us why the pipeline is worth $30 as you have stated in several post with your fluffy statements, give me details on how you get to that number not fluff. The bottom line pinhead is just a faceless pumper who bought the stock at $20

 
NBIX
13.92+0.14(+1.02%)1:08 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.